Many people have gotten off insulin and/or lost significant weight thanks to Ozempic. This is the brand name of a drug with semaglutide as the active ingredient and has been prescribed to many patients struggling with diabetes. Semaglutide is also the active ingredient in Wegovy. This is the brand name for a similar medication that’s essentially a higher-dose version of Ozempic and is intended primarily for individuals looking to lose weight.
However, like most other prescription medications, Ozempic and Wegovy have their fair share of side effects and issues. One of the most publicized and unpleasant is gastroparesis, which has led to some legal action that I wrote about last year. Then in July 2024, a study published by JAMA Ophthalmology indicated a possible link between semaglutide and nonarteritic anterior ischemic optic nerve neuropathy. Let’s take a closer look at this study and what it could mean if you or someone you know is taking Ozempic or Wegovy.
What Is Nonarteritic Anterior Ischemic Optic Neuropathy?